Purchase Order 75N91024P00472
- Not listed
- The National Cancer Institute awarded a $45,624.80 firm fixed-price purchase order to Leica Microsystems Inc. on April 27, 2026, for comprehensive maintenance and repair services on a Leica Stellaris 8 FLIM confocal microscope located at the NCI CCR Microscopy Core in Bethesda, Maryland. The 12-month contract, which extends through April 26, 2027, requires Leica to provide unlimited on-site repairs, replacement parts, one preventative maintenance inspection, firmware and software updates, and...
- The National Cancer Institute awarded a firm fixed-price purchase order to Leica Microsystems Inc. (Leica Biosystems division) for a maintenance service agreement valued at $60,663.20, with performance in Bethesda, Maryland and completion by February 28, 2027. This non-set-aside contract, awarded March 1, 2026, represents a continuation of the agency's relationship with Leica, a specialized manufacturer of microscopy systems and laboratory instrumentation that serves critical roles in federal...
- The National Cancer Institute awarded a firm fixed-price purchase order valued at $402,725 to Leica Microsystems Inc. (through its Leica Biosystems division) for maintenance services on specialized confocal microscopy equipment supporting the Thoracic and GI Malignancies Branch. The contract covers preventative maintenance, on-site emergency repairs, software support, and parts replacement for two government-owned instruments: a Leica Basic Module TCS SP8 LIAchroic IR microscope and a Leica...
- The National Cancer Institute (NCI), an agency within the National Institutes of Health, awarded a $545,992.04 firm fixed-price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on March 27, 2025, for preventative maintenance and emergency repair services for three government-owned Leica imaging devices supporting cancer research at the Center for Cancer Research in Bethesda, Maryland. The devices include a Leica Stellaris 5 confocal microscope, a Leica CellDIVE microscope,...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at approximately $15,758 to Leica Microsystems Inc.'s Leica Biosystems Division. The contract is for maintenance services to support the agency's cancer research efforts. As the prime contractor, Leica Biosystems will perform the requested maintenance work at its facility located in Riverwoods, Illinois. No subcontractors or set aside...
- The National Cancer Institute awarded a $125,135.79 firm fixed-price purchase order to Leica Microsystems Inc.'s Leica Biosystems division for a service agreement covering the Leica BOND RXM, an automated immunohistochemistry staining system widely used in cancer research and diagnostic pathology. The contract, awarded on May 11, 2026, with an ultimate completion date of May 10, 2031, will be performed at Leica's facility in Riverwoods, Illinois. This award was made on an unrestricted, open...
- This federal contract award is for a maintenance agreement between the National Cancer Institute (NCI) and Leica Microsystems Inc. The contract, valued at $24,035.40, is a firm fixed price purchase order without a set-aside designation. The award date is November 10, 2024, with a completion date of July 10, 2025. Leica Microsystems Inc., a manufacturer of microscopes, scientific instruments, and imaging equipment, is the prime contractor. The contract is likely related to the maintenance and...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a one-year, $20,412.80 firm fixed price purchase order to Leica Microsystems Inc., Leica Biosystems Division, for maintenance services. The place of performance will be Leica Biosystems' facility located in Riverwoods, Illinois. The contract supports the National Cancer Institute's research efforts through the provision of maintenance for scientific equipment. No subcontractors or set...
- The National Cancer Institute (NCI) awarded a $158,311 firm fixed price purchase order to Leica Microsystems Inc. for annual service maintenance of a Leica SP8 WLL confocal scanning microscope with Falcon module located at the Laboratory of Cell and Molecular Biology (LCMB) in Bethesda, Maryland. The award, issued on March 1, 2026, was issued without set-aside designation and will extend through February 28, 2029. The contract encompasses preventive maintenance services including equipment...
- This is a $10,158.72 firm fixed-price purchase order awarded by the National Cancer Institute to Leica Microsystems Inc., a for-profit manufacturer of specialized microscopes, scientific instruments, and imaging equipment. The contract is for a maintenance agreement on Leica's advanced microscopy products, including Stellaris confocal microscopes, Aperio digital slide scanners, and other imaging platforms. Leica Microsystems has established itself as a critical vendor for scientific research,...
The National Cancer Institute awarded a $202,490.42 firm fixed price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on June 13, 2024, for preventive maintenance services on one Leica Stellaris microscope under a Premium Care service agreement. The contract extends through June 12, 2029, and will be performed at Leica's facility in Riverwoods, Illinois. No small business set-aside designation was used in this competitive award to the original equipment manufacturer, reflecting Leica's established position as the primary service provider for its proprietary microscopy systems within the federal research infrastructure. Leica Microsystems has demonstrated substantial capacity to support the National Cancer Institute's research mission through an extensive history of federal contracts spanning specialized microscopy equipment, maintenance services, and laboratory instrumentation. The company maintains established relationships across the National Institutes of Health network and other civilian agencies, with prior awards ranging from approximately $7,500 to over $1.4 million. This preventive maintenance contract supports operational continuity of advanced confocal microscopy capabilities critical to cancer research and diagnostic operations, positioning the Stellaris system as an essential tool within the NCI's laboratory infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $40.5k | 3/18/26 | |
| P00001 | Exercise an Option | $39.3k | 6/12/25 | |
| Not listed | Not listed | $38.1k | 6/10/24 |